Clinical Trial Update: Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating an anti-PD-1 antibody in combination with radiotherapy for early-stage favorable Classical Hodgkin Lymphoma; the study is currently no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• Anti-PD-1 antibody

Snippet

Sponsor: University of Cologne | Conditions: Classical Hodgkin Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING